Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
5.
Br J Cancer ; 117(5): 656-665, 2017 Aug 22.
Article in English | MEDLINE | ID: mdl-28751755

ABSTRACT

BACKGROUND: Translationally controlled tumour protein (TCTP) is an antiapoptotic protein highly conserved through phylogeny. Translationally controlled tumour protein overexpression was detected in several tumour types. Silencing TCTP was shown to induce tumour reversion. There is a reciprocal repression between TCTP and P53. Sertraline interacts with TCTP and decreases its cellular levels. METHODS: We evaluate the role of TCTP in melanoma using sertraline and siRNA. Cell viability, migration, and clonogenicity were assessed in human and murine melanoma cells in vitro. Sertraline was evaluated in a murine melanoma model and was compared with dacarbazine, a major chemotherapeutic agent used in melanoma treatment. RESULTS: Inhibition of TCTP levels decreases melanoma cell viability, migration, clonogenicity, and in vivo tumour growth. Human melanoma cells treated with sertraline show diminished migration properties and capacity to form colonies. Sertraline was effective in inhibiting tumour growth in a murine melanoma model; its effect was stronger when compared with dacarbazine. CONCLUSIONS: Altogether, these results indicate that sertraline could be effective against melanoma and TCTP can be a target for melanoma therapy.


Subject(s)
Biomarkers, Tumor/antagonists & inhibitors , Biomarkers, Tumor/genetics , Melanoma/genetics , RNA, Messenger/metabolism , Sertraline/pharmacology , Skin Neoplasms/drug therapy , Animals , Antineoplastic Agents, Alkylating/therapeutic use , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/genetics , Cell Survival/drug effects , Dacarbazine/therapeutic use , Female , Gene Expression/drug effects , Gene Expression/genetics , Gene Silencing , Humans , Melanoma/metabolism , Melanoma, Experimental/drug therapy , Mice , Mice, Inbred C57BL , RNA, Small Interfering/genetics , Sertraline/therapeutic use , Transfection , Tumor Protein, Translationally-Controlled 1 , Tumor Stem Cell Assay , Tumor Suppressor Protein p53/metabolism
6.
Diabet Med ; 32(5): 653-6, 2015 May.
Article in English | MEDLINE | ID: mdl-25655786

ABSTRACT

AIM: To investigate the relationship between plasma betatrophin concentrations and insulin secretion capacity in people with Type 2 diabetes. METHODS: Glucagon stimulation tests (1 mg) were performed in 70 people with Type 2 diabetes after an overnight fast. Plasma betatrophin concentrations were measured using an enzyme-linked immunosorbent assay. Insulin secretion capacity was evaluated by measuring increments of C-peptide concentration in response to glucagon stimulation, and creatinine clearance was determined by comparing creatinine concentrations in serum and 24-h urine samples. RESULTS: Plasma betatrophin concentrations were positively correlated with duration of Type 2 diabetes (r = 0.34, P = 0.003), and negatively correlated with increments of C-peptide concentration (r = 0.37, P = 0.001) and creatinine clearance (r = 0.37, P = 0.001). The correlation with increments of C-peptide concentration remained significant after adjustment for age and duration of Type 2 diabetes (r = 0.25, P = 0.037). Multivariate analysis identified age and increments of C-peptide concentration as independent factors associated with plasma betatrophin levels. CONCLUSION: Plasma betatrophin levels inversely correlate with insulin secretion capacity, suggesting that betatrophin levels are regulated by insulin secretion capacity in humans.


Subject(s)
Diabetes Mellitus, Type 2/blood , Glucagon/pharmacology , Insulin-Secreting Cells/metabolism , Insulin/blood , Peptide Hormones/blood , Aged , Angiopoietin-Like Protein 8 , Angiopoietin-like Proteins , Biomarkers/blood , C-Peptide/blood , Creatinine/blood , Creatinine/urine , Diabetes Mellitus, Type 2/physiopathology , Female , Humans , Insulin-Secreting Cells/physiology , Male , Middle Aged , Multivariate Analysis , Stimulation, Chemical , Time Factors
7.
J Sports Med Phys Fitness ; 55(10): 1072-81, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25303165

ABSTRACT

AIM: It is unclear whether the slowed time constant of phase II in pulmonary oxygen uptake on-kinetics (V̇O2τ) in unfit and inactive men would be shortened by low exercise intensity (low-intensity) walking training. We therefore tested the hypothesis that the slowed V̇O2τ in sedentary population would speed up due to low-intensity walking training with high volume. METHODS: Ten unfit and inactive male subjects (aged 26 to 50 yrs) underwent a low-intensity (30-40% of V̇O2max), long-duration (>60 min) training in the form of walking exercise 3-4 times a week for 12 weeks. We prospectively collected data on anthropometric, maximal oxygen uptake (V̇O2max), time constant of heart rate (HRτ) and V̇O2τ before training (0 wk; Pre) and every six weeks (6 wk; Mid, 12 wk; Post) from the beginning of the training. RESULTS: Anthropometric variables and V̇O2max showed no significant changes throughout the training program, whereas HRτ showed a tendency to be shortened with a progress of the training with no significant change. The slowed V̇O2τ at Pre (47.6±5.6 s) remained almost unchanged at Mid (48.8±4.9 s), but had a significant decrease at Post (40.5±7.9 s, P<0.05). CONCLUSION: In this study acceleration of the slowed V̇O2τ due to low-intensity walking training is thought to occur presumably owing to an improved matching of oxygen delivery to oxygen utilization at the site of gas exchange in active muscle tissue. We concluded that low-intensity walking training at beginning stage of training could contribute to the acceleration of the slowed V̇O2τ in unfit and inactive subjects.


Subject(s)
Bicycling , Exercise Test , Exercise/physiology , Heart Rate/physiology , Oxygen Consumption/physiology , Oxygen/metabolism , Adaptation, Physiological , Adult , Biomarkers/blood , Humans , Kinetics , Lactic Acid/blood , Male , Middle Aged , Pulmonary Gas Exchange
8.
Horm Metab Res ; 42(5): 311-7, 2010 May.
Article in English | MEDLINE | ID: mdl-20213584

ABSTRACT

It has been reported that the immunosuppressant rapamycin decreases the viability of pancreatic beta cells. In contrast, exendin-4, an analogue of glucagon-like peptide-1, has been found to inhibit beta cell death and to increase beta cell mass. We investigated the effects of exendin-4 on the cytotoxic effect of rapamycin in beta cells. Incubation with 10 nM rapamycin induced cell death in 12 h in murine beta cell line MIN6 cells and Wistar rat islets, but not when coincubated with 10 nM exendin-4. Rapamycin was found to increase phosphorylation of c-Jun amino-terminal kinase (JNK) and p38 in 30 minutes in MIN6 cells and Wistar rat islets while exendin-4 decreased their phosphorylation. Akt and extracellular signal-regulated kinase (ERK) were not involved in the cytoprotective effect of exendin-4. These results indicate that exendin-4 may exert its protective effect against rapamycin-induced cell death in pancreatic beta cells by inhibiting JNK and p38 signaling.


Subject(s)
Antibiotics, Antineoplastic/antagonists & inhibitors , Antibiotics, Antineoplastic/toxicity , Insulin-Secreting Cells/drug effects , MAP Kinase Kinase 4/antagonists & inhibitors , Peptides/pharmacology , Sirolimus/antagonists & inhibitors , Sirolimus/toxicity , Venoms/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Blotting, Western , Cell Death/drug effects , Cell Survival/drug effects , Culture Media , Cyclic AMP-Dependent Protein Kinases/physiology , Dose-Response Relationship, Drug , Exenatide , Extracellular Signal-Regulated MAP Kinases/physiology , Flow Cytometry , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/pathology , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Phosphatidylinositol 3-Kinases/physiology , Phosphorylation/drug effects , Rats , Rats, Wistar
9.
Kyobu Geka ; 60(2): 89-93; discussion 93-6, 2007 Feb.
Article in Japanese | MEDLINE | ID: mdl-17305072

ABSTRACT

To prevent patient-prosthesis mismatch (PPM) after aortic valve replacement (AVR), we set up our original standard criteria for the selection of the size of the prosthetic valve. We also routinely perform supra-annular enlargement in patients with small aortic annuli. The objective of this study was to assess the impact of our procedure on the postoperative cardiac function of patients suffering from aortic stenosis (AS). We retrospectively reviewed 102 consecutive surgical patients with AS from 1999 to 2004. The patients were classified into the following 3 groups based on the sizes of their prosthesis (group S : 19 mm prosthesis, n = 34; group M : 21 mm prosthesis, n = 51; and group L : > 23 mm prosthesis, n = 17). Cardiac function was evaluated using echocardiography preoperatively, immediately postoperatively, and 6 months after the operation. There were no hospital deaths during the study period. A favorable hemodynamic outcome of all 3 groups was achieved. Our surgical strategy for AS was thought to be useful to prevent PPM after AVR.


Subject(s)
Aortic Valve Stenosis/physiopathology , Aortic Valve/surgery , Heart Valve Prosthesis Implantation , Heart/physiopathology , Adult , Aged , Aged, 80 and over , Aortic Valve Stenosis/surgery , Bioprosthesis , Echocardiography , Female , Heart Valve Prosthesis , Humans , Male , Middle Aged , Postoperative Period , Prosthesis Fitting , Retrospective Studies
10.
Kyobu Geka ; 59(11): 1046-7, 2006 Oct.
Article in Japanese | MEDLINE | ID: mdl-17058669

ABSTRACT

A segmental mitral suture annuloplasty technique is consisted of double-layer sutures anchored in the fibrous trigone on the valve repair side and along the annulus to the midpoint of the posterior leaflet. This suture technique is an alternative of Paneth Burr method using only one-side of the procedure. We recommend this technique especially in cases of mitral regurgitation which can be repaired by a simple resection-suture technique for posterior leaflet, and not in cases of severe annular dilatation, rheumatic, or ischemic diseases. We have examined this technique in 40 cases over the last 8 years and the results showed no recurrence of the mitral regurgitation.


Subject(s)
Mitral Valve Prolapse/surgery , Mitral Valve/surgery , Cardiac Surgical Procedures/methods , Humans
11.
Kyobu Geka ; 59(4): 289-93, 2006 Apr.
Article in Japanese | MEDLINE | ID: mdl-16613146

ABSTRACT

BACKGROUND: We routinely perform supra-annular patch enlargement as a strategy to avoid patient-prosthesis mismatch (PPM) in patients with a small aortic annulus who are undergoing aortic valve replacement (AVR). METHOD: We performed a retrospective review of 128 consecutive single AVR patients from 1999 to 2005. Of these, 34 patients underwent supra-annular patch enlargement. The enlargement was selectively performed in patients at risk of PPM. This involved patch extension of the aortotomy just above the annulus of noncoronary sinus, and valve implantation with stitches placed directly on the patch. Along with this procedure, AVR with a valve size appropriate to body surface area (BSA) was performed. RESULT: Of these patients, 74% were female and the mean BSA was less than 1.50 m2. The enlargement required an average of 33 minutes of additional aortic clamp time. The 30-day mortality was 0%. A favorable hemodynamic outcome was achieved. CONCLUSION: Our results show that supra-annular patch enlargement can be performed with minimal added risk, relative to standard root enlargement and a satisfactory hemodynamic status can be achieved by employing this procedure.


Subject(s)
Aortic Valve Stenosis/surgery , Aortic Valve/surgery , Heart Valve Prosthesis Implantation/methods , Aged , Bioprosthesis , Female , Heart Valve Prosthesis , Humans , Male , Middle Aged , Prognosis , Prosthesis Fitting/methods , Retrospective Studies
12.
J Environ Qual ; 30(5): 1693-8, 2001.
Article in English | MEDLINE | ID: mdl-11577878

ABSTRACT

Shifts in manure phosphorus (P) chemical forms and pool sizes induced by water treatment residuals and industrial mineral by-products are largely undefined. We conducted a manure P fractionation study to determine mechanisms of reduction of dissolved reactive phosphorus (DRP) in poultry manure upon mineral by-product additions. The effects of composting on the P immobilization efficacy of the by-products were determined using laboratory self-heating composting simulators. The mineral by-products included an aluminum-water treatment residual (Al-WTR) and an iron-rich titanium-processing by-product. The noncomposted manure averaged 0.11 g g(-1) of total P as DRP forms. The by-products significantly reduced manure DRP, by an average of 39 and 48% in the Al- and the Fe-treated manure, respectively. The by-products also reduced the 0.5 M NH4F-extractable phosphorus (FEP) fraction. Shifts in P forms between FEP and 0.1 M NaOH-extractable phosphorus (SHEP) depended upon the Al and Fe contents of the by-products while the combined FEP + SHEP pool remained constant. Phosphate sorption measurements supported the observations that the Fe-rich by-product was more effective at reducing manure DRP and enhancing the formation of SHEP forms at the expense of FEP than the Al-WTR. Composting had no effect on the efficacy of either by-product to reduce DRP. Potential mechanisms of enhanced P stabilization in treated manure upon composting included chemical shifts from the DRP and FEP fractions to the citrate-bicarbonate-dithionite extractable P fraction. Thus, the choice of P immobilization agents affected the stability of immobilized P forms and should be taken into consideration in developing manure processing and nutrient stabilization methods.


Subject(s)
Bacteria, Aerobic/physiology , Manure , Phosphorus/chemistry , Phosphorus/metabolism , Soil Pollutants/analysis , Animals , Biological Availability , Conservation of Natural Resources , Environmental Pollution/prevention & control , Poultry , Refuse Disposal , Solubility
13.
Dentomaxillofac Radiol ; 30(4): 214-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11681483

ABSTRACT

OBJECTIVES: To evaluate the relationship between joint effusion, contrast enhancement of effusion, nitric oxide concentration in TMJ fluid and TM joint pain. METHODS: Nonenhanced T1- and T2-weighted and gadolinium-enhanced T1-weighted spin-echo sequences were performed in 77 patients with TMD. The nitric oxide concentration in TMJ fluid was analysed spectrophotometrically by the Griess reaction. RESULTS: Some or marked effusion was seen in five (9%) of the 56 asymptomatic joints and in 55 (56%) of the 98 symptomatic joints. The prevalence of contrast enhancement of joint effusion was significantly higher in the joint pain group than in the joint sound or asymptomatic joint groups (chi2 test, P<0.001). On postcontrast T1-weighted images, there was no evidence of synovial proliferation in patients with TMD. Anterior disk displacement without reduction was detected in 93% of the TMJs with marked effusion. The degree of joint pain correlated with raised nitric oxide concentration (Spearman's rank correlation, P<0.05). CONCLUSIONS: Painful joints are more likely to demonstrate contrast enhancement of joint effusion. Nitric oxide concentration in TMJ fluid is closely associated with inflammatory changes and painful TM joints.


Subject(s)
Arthritis/physiopathology , Free Radical Scavengers/analysis , Nitric Oxide/analysis , Synovial Fluid/physiology , Temporomandibular Joint Disorders/physiopathology , Adolescent , Adult , Aged , Arthritis/metabolism , Arthritis/pathology , Chi-Square Distribution , Colorimetry , Contrast Media , Ethylenediamines , Female , Gadolinium , Humans , Image Enhancement/methods , Image Processing, Computer-Assisted/methods , Joint Dislocations/metabolism , Joint Dislocations/pathology , Joint Dislocations/physiopathology , Magnetic Resonance Imaging/methods , Male , Middle Aged , Spectrophotometry , Statistics, Nonparametric , Sulfanilamides , Synovial Fluid/chemistry , Synovial Membrane/pathology , Temporomandibular Joint Disc/pathology , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology
15.
J Cell Physiol ; 189(1): 72-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11573206

ABSTRACT

Adipose tissue expresses a variety of genes including tumor necrosis factor alpha and type-1 plasminogen activator inhibitor (PAI-1); and these factors, produced by adipocytes, may be associated with the risk of coronary events in obesity. In this study, we characterized the production of fibrinolytic factors including tissue-type plasminogen activator (tPA), urokinase-type PA (uPA), and PAI-1 in the differentiation of preadipocytes, and examined the hormonal regulation of these fibrinolytic factors in mature adipocytes. Mouse 3T3-L1 preadipocytes were employed as a model of adipocytes. Adipocyte differentiation was induced by insulin, dexamethasone, and 3-isobutyl-1-methyl xanthine (IBMX). alpha-Glycerophosphate dehydrogenase (GPDH) activity and glucose transporter 4 (GLUT4) mRNA, indices for adipocyte maturation, were induced on Day 4, and gradually increased. GPDH activity reached its maximum level on Day 14. The level of tPA, a major PA in preadipocytes, dramatically decreased with differentiation. On the other hand, that of uPA reciprocally increased. PAI-1 production was also dramatically induced concomitant with differentiation. In mature adipocytes, uPA production was dominant (25 microg/ml/24 h vs. 0.8 microg/ml/24 h for tPA). Total PA activity in the mature adipocytes was reduced by insulin or dexamethasone, but not by glucagon. Insulin, IBMX, and dexamethasone significantly decreased both uPA and tPA production, and increased PAI-1 production. Glucagon had no effect on the production of these fibrinolytic factors. Our results reveal that uPA is one of the markers for the differentiation of 3T3-L1 cells and that insulin, IBMX, and dexamethasone are potent regulators of the fibrinolytic activity in differentiated 3T3-L1 cells, reciprocally affecting PA and PAI-1 levels in them.


Subject(s)
Adipocytes/metabolism , Hormones/pharmacology , Muscle Proteins , Plasminogen Activator Inhibitor 1/metabolism , Tissue Plasminogen Activator/metabolism , Urokinase-Type Plasminogen Activator/metabolism , 1-Methyl-3-isobutylxanthine/pharmacology , 3T3 Cells , Adipocytes/physiology , Animals , Cell Differentiation , Dexamethasone/pharmacology , Glucose Transporter Type 4 , Glycerolphosphate Dehydrogenase/biosynthesis , Glycerolphosphate Dehydrogenase/genetics , Insulin/pharmacology , Kinetics , Mice , Monosaccharide Transport Proteins/biosynthesis , Monosaccharide Transport Proteins/genetics , RNA, Messenger/biosynthesis , Stem Cells/cytology , Stem Cells/drug effects , Stem Cells/metabolism , Urokinase-Type Plasminogen Activator/genetics
16.
Kyobu Geka ; 54(3): 254-7, 2001 Mar.
Article in Japanese | MEDLINE | ID: mdl-11244762

ABSTRACT

We report a case of traumatic diaphragmatic hernia (TDH) resulting from continuous thoracic drainage and was successfully treated by surgical procedures. A 45-year-old man was admitted to our department due to shock after a blunt trauma by a traffic accident. As he revealed left hemothorax on admission, continuous thoracic drainage was performed. Soon after the drainage, diaphragmatic hernia occurred as an incarceration of the spleen into the thoracic cavity. In the literature, 80 cases with TDH have been reported in Japan since 1986. The purpose of this study is to discuss the mechanism of TDH in the acute phase and to consider its appropriate diagnostic tools. The following two results were obtained. (1) TDH may be appeared during the clinical course, especially after a continuous thoracic drainage, in patients with damaged diaphragm by blunt traumas. (2) CT is the most effective tool for the diagnosis of TDH.


Subject(s)
Drainage/adverse effects , Hernia, Diaphragmatic, Traumatic/surgery , Hernia, Diaphragmatic, Traumatic/etiology , Humans , Male , Middle Aged , Thorax
18.
Nucleic Acids Symp Ser ; (44): 219-20, 2000.
Article in English | MEDLINE | ID: mdl-12903347

ABSTRACT

In vitro selection or systematic evolution of ligand by exponential enrichment (SELEX) has been devised for the identification of high-affinity oligonucleotide aptamers to target molecules. However, the selection process is repetitive and time-consuming. We have developed an automatic for in vitro selection by assembling an affinity chromato-column, a PCR thermal cycler, a HPLC and a sample operation system. Several molecular biology methods were optimized for the machine. Automated selection was used to generate nucleic acid aptamers interacting specifically with an environmental contaminant.


Subject(s)
Oligodeoxyribonucleotides/genetics , Oligodeoxyribonucleotides/isolation & purification , Automation , Base Sequence , Chromatography, Affinity , Chromatography, High Pressure Liquid , DNA, Single-Stranded/genetics , DNA, Single-Stranded/isolation & purification , Genetic Techniques , Polymerase Chain Reaction , Selection, Genetic
19.
J Exp Med ; 188(11): 1985-92, 1998 Dec 07.
Article in English | MEDLINE | ID: mdl-9841913

ABSTRACT

To elucidate the role of A1, a new member of the Bcl-2 family of apoptosis regulators active in hematopoietic cell apoptosis, we established mice lacking A1-a, a subtype of the A1 gene in mice (A1-a-/- mice). Spontaneous apoptosis of peripheral blood neutrophils of A1-a-/- mice was enhanced compared with that of either wild-type mice or heterozygous mutants (A1-a+/- mice). Neutrophil apoptosis inhibition induced by lipopolysaccharide treatment in vitro or transendothelial migration in vivo observed in wild-type mice was abolished in both A1-a-/- and A1-a+/- animals. On the other hand, the extent of tumor necrosis factor alpha-induced acceleration of neutrophil apoptosis did not differ among A1-a-/-, A1-a+/-, and wild-type mice. The descending order of A1 mRNA expression was wild-type, A1-a+/-, and A1-a-/-. Taken together, these results suggest that A1 is involved in inhibition of certain types of neutrophil apoptosis.


Subject(s)
Apoptosis/immunology , DNA-Binding Proteins/genetics , Gene Expression Regulation/immunology , Homeodomain Proteins , Neutrophil Activation/genetics , Neutrophils/immunology , Proto-Oncogene Proteins c-bcl-2/genetics , Repressor Proteins , Saccharomyces cerevisiae Proteins , Animals , Apoptosis/genetics , Base Sequence , DNA-Binding Proteins/immunology , Mice , Mice, Knockout , Minor Histocompatibility Antigens , Molecular Sequence Data , Neutrophils/pathology , Proto-Oncogene Proteins c-bcl-2/immunology , Replication Protein C
SELECTION OF CITATIONS
SEARCH DETAIL
...